Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

BACKGROUND: Immune checkpoint inhibition, combined with novel biomarkers, may provide alternative pathways for treating chemotherapy-resistant triple-negative breast cancer (TNBC). This study investigates the expression of new immune checkpoint receptors, including CD155 and CD73, which play a role...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabioglu, Neslihan, Bayram, Aysel, Emiroglu, Selman, Onder, Semen, Karatay, Huseyin, Oner, Gizem, Tukenmez, Mustafa, Muslumanoglu, Mahmut, Igci, Abdullah, Aydiner, Adnan, Saip, Pinar, Yavuz, Ekrem, Ozmen, Vahit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374450/
https://www.ncbi.nlm.nih.gov/pubmed/37519808
http://dx.doi.org/10.3389/fonc.2023.1165257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374450/
https://www.ncbi.nlm.nih.gov/pubmed/37519808
http://dx.doi.org/10.3389/fonc.2023.1165257

Ejemplares similares